The ENGAGE study: Integrating neuroimaging, virtual reality and smartphone sensing to understand self-regulation for managing depression and obesity in a precision medicine model
- PMID: 29074231
- PMCID: PMC8109191
- DOI: 10.1016/j.brat.2017.09.012
The ENGAGE study: Integrating neuroimaging, virtual reality and smartphone sensing to understand self-regulation for managing depression and obesity in a precision medicine model
Abstract
Precision medicine models for personalizing achieving sustained behavior change are largely outside of current clinical practice. Yet, changing self-regulatory behaviors is fundamental to the self-management of complex lifestyle-related chronic conditions such as depression and obesity - two top contributors to the global burden of disease and disability. To optimize treatments and address these burdens, behavior change and self-regulation must be better understood in relation to their neurobiological underpinnings. Here, we present the conceptual framework and protocol for a novel study, "Engaging self-regulation targets to understand the mechanisms of behavior change and improve mood and weight outcomes (ENGAGE)". The ENGAGE study integrates neuroscience with behavioral science to better understand the self-regulation related mechanisms of behavior change for improving mood and weight outcomes among adults with comorbid depression and obesity. We collect assays of three self-regulation targets (emotion, cognition, and self-reflection) in multiple settings: neuroimaging and behavioral lab-based measures, virtual reality, and passive smartphone sampling. By connecting human neuroscience and behavioral science in this manner within the ENGAGE study, we develop a prototype for elucidating the underlying self-regulation mechanisms of behavior change outcomes and their application in optimizing intervention strategies for multiple chronic diseases.
Keywords: Behavior change; Depression; Neuroimaging; Obesity; Self-regulation; Virtual reality.
Copyright © 2017. Published by Elsevier Ltd.
Conflict of interest statement
Disclosures
LMW: Received direct (non-salary) research funding from Brain Resource Pty Ltd. as cross-site Academic Principal Investigator lead for the ISPOT-D study (2008–2013).
TS: Consulting fees from A/S H. Lundbeck, Sunovion, Merck & Co, and Astra Zeneca.
AP, ANG-P, LGS, MK, MDS, OG, JM, PWL, PD, BW, CC, WG, LMP, JMSm, MAL, EMV, MS, JMSi, JM: Nothing to disclose.
Figures

References
-
- Achtziger A, Gollwitzer PM, & Sheeran P (2008). Implementation intentions and shielding goal striving from unwanted thoughts and feelings. Personality & Social Psychology Bulletin, 34(3), 381–393. - PubMed
-
- Ashburner J, & Friston KJ (2005). Unified segmentation. Neuroimage, 26, 839–851. - PubMed
-
- Atlantis E, & Baker M (2008). Obesity effects on depression: Systematic review of epidemiological studies. International Journal of Obesity, 32, 881–891. - PubMed
-
- Bailenson JN, Pontikakis ED, Mauss IB, Gross JJ, Jabon ME, Hutcherson CAC, et al. (2008). Real-time classification of evoked emotions using facial feature tracking and physiological responses. International Journal of Human-computer Studies, 66(5), 303–317.
-
- Bjerkesset O, Romundstad P, Evans J, & Gunnell D (2008). Association of adult body mass index and height with anxiety, depression, and suicide in the general population: The HUNT study. American Journal of Epidemiology, 167(2), 193–202. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous